CoverDiscovery on Target is CHI’s premier Drug Discovery event that brings to light the latest developments in the science and technologies underlying cellular pathways and drug targets. In its seventh year of production Discovery on Target, covers a diverse set of topics and captures an international audience spanning both industry and academia. This year, the event comprised of seven conference programs showcasing novel targets and approaches for research in ion channels, diabetes, kinases, G-protein coupled receptors, histone deacetylases and for RNA Interference-based screening tools and therapeutics.    Read more > 

Concurrent Tracks
November 2-3, 2009

Concurrent Tracks
November 3-4, 2009


Clapham David David Clapham, M.D., Ph.D.,
Howard Hughes Medical Institute

Dabrowski Michael Michael Dabrowski, Ph.D.,

Gregory J. Kaczorowski Gregory J. Kaczorowski,
School; Robert Wood Johnson Medical School

John Maraganore John M. Maraganore, Ph.D.,
Alnylam Pharmaceuticals, Inc.

Graeme Milligan, Ph.D Graeme Milligan, Ph.D.,
University of Glasgow

Steve Nissen Steven E. Nissen, M.D.,
M.A.C.C., Cleveland Clinic Foundation

David Root, Ph.D.,
The RNAi Consortium Broad Institute of MIT and Harvard

Anja J. Stauber, Ph.D., DABT,
Eli Lilly and Company

Eric M. Verdin, M.D.,
University of California, San Francisco

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 

2014 Discovery on Target Brochure  

 green arrow FINAL BROCHURE 



green arrow VIEW ALL SPONSORS 



The exhibit hall was sold out in 2013, so please contact us early to reserve your place. To customize your sponsorship or exhibit package for 2014, contact:

Jon Stroup
Business Development Manager

2014 Discovery On Target CAG 



October 8 – 9

Targeting Epigenetic Readers and
Chromatin Remodelers

Targeting the Ubiquitin Proteasome System  

Big Data Analytics and Solutions  

GPCR-Based Drug Discovery  

RNAi for Functional Genomics Screening
– Part 1

Protein-Protein Interactions as Drug Targets  

Antibodies Against Membrane Protein Targets
– Part 1

October 9 – 10

Targeting Histone Methyltransferases and Demethylases  

Screening Drug Transporter Proteins  

Maximizing Efficiency in Discovery  

GPCR-Targeted Therapeutics  

Genome Editing for Functional Genomics
Screens – Part 2

Cancer Metabolism  

Antibodies Against Membrane Protein Targets
– Part 2


October 7

Next Generation Histone Deacetylase Inhibitors  


October 7

SC1: Designing Scalable Software Systems for Big Data Analytics  

SC2: Approaches for Biologically-Relevant Chemical Diversity  

SC3: Setting Up Effective RNAi Screens: From Design to Data to Validation  

SC4: Targeting Protein-Protein Interactions  

SC5: GPCR Structure-Based Drug Discovery  

SC6: Advances in Metagenomic Drug Discovery for New Anti-Infective Agents  

SC7: Targeting of GPCRs with Monoclonal Antibodies  

SC8: A Primer to Gene Editing: Tools and Applications  

SC9: Introduction to Targeted Covalent Inhibitors  

October 9

SC10: Setting Up Effective Functional Screens Using 3D Cell Cultures  

SC11: Integration of BDDCS and Extended Clearance Principles  

SC12: Introduction to Allosteric Modulators and Biased Ligands of GPCRs  

SC13: Introduction to Drug Metabolism